We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microsemi CRP Automated Hematology Analyzer Evaluated

By LabMedica International staff writers
Posted on 05 Feb 2015
Print article
HORIBA Medicals\'s Microsemi CRP automated hematology analyzer
The Microsemi CRP automated hematology analyzer (Photo courtesy of HORIBA JAPAN)
Complete blood counts (CBC) including white blood cell count (WBC) differentials and C-reactive protein (CRP) have been frequently utilized as the biomarkers for inflammatory diseases such as bacterial infection.

An automated hematology analyzer has been developed which can simultaneously measure CBC including three-part WBC differential (3-Diff) and CRP using ethylenediaminetetraacetic acid dipotassium salt dihydrate (EDTA-2K) anticoagulated whole blood without centrifugation for serum preparation.

Scientists at HORIBA Medical (Kyoto, Japan) used the company’s automated hematology analyzer, The Microsemi CRP, which is equipped with the electrical resistance method for CBC with 3-Diff of granulocytes (GRA) including neutrophils eosinophils and basophils, lymphocytes (LYM), and monocytes (MON). CRP is measured with the latex immune turbidimetry method following the prompt hemolyzation of EDTA-2K anticoagulated whole blood. The obtained value is then converted into plasma concentration according to hematocrit (HCT %) of respective sample to finally provide as ‘whole blood CRP.’

Correlation tests for the Microsemi CRP were compared with those of Micros CRP200, a preceding Horiba Medical model, and also those of the ADVIA 2120i (Siemens; Munich, Germany) routine hematology analyzer. The results of fresh whole blood and serum CRP obtained using Micros CRP200 were compared with those of serum CRP obtained using HITACHI 7600 routine analyzer (Tokyo, Japan).

The CBC data examined using Microsemi CRP showed excellent correlation with the previous model, Micros CRP200and also those obtained using the routine analyzer, ADVIA 2120i. In regards to the 3-Diff, both GRA (%) and LYM (%) showed the excellent correlation coefficient between Microsemi CRP and Micros CRP200 as well as ADVIA 2120i. (MON (%) showed good correlation between Microsemi CRP and Micros CRP200, but lower correlation between Microsemi CRP and ADVIA 2120. CRP data showed the good correlation with HITACHI 7600 and Micros CRP200.

The authors concluded that Microsemi CRP was a convenient laboratory analyzer which could provide the clinically reliable data about CBC including 3-Diff and CRP using only 18 μL whole blood within approximately four minutes. Therefore, Microsemi CRP seemed suitable in the setting of point of care testing (POCT) for the patients with inflammatory diseases such as bacterial infection, especially for pediatric ones in whom sufficient volume of samples necessary to simultaneous measurement of CBC including WBC Diff and CRP using the routine analyzers. The study was first published online on December 11, 2014, in the International Journal of Laboratory Hematology.

Related Links:

HORIBA Medical
Siemens
HITACHI 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.